S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SRTS Sensus Healthcare Inc

3.76

0.00 (0.00%)

Pre Market

Last Updated: 06:00:00

Delayed by 15 minutes

Sensus Healthcare EPS beats by $0.17, beats on revenue

To read the full story on Seeking Alpha, click here.

Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Sensus Healthcare Charts.

Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Sensus Healthcare Charts.

Sensus Healthcare Inc News

Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia
Monday 6 May 2024 (1 day ago) • GlobeNewswire Inc.

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
Thursday 25 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
Thursday 18 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Sensus Healthcare to Participate in the 36th Annual Roth Conference
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
Tuesday 6 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

Sensus Healthcare Announces Retirement of Director Samuel O’Rear
Thursday 1 February 2024 (3 months ago) • GlobeNewswire Inc.

More Sensus Healthcare Inc News Articles

Greene Concepts (PK)

Movement Industries (PK)

Mike The Pike Productions (CE)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Kraig Biocraft Laborator... (QB)

Innerscope Hearing Techn... (PK)

Mullen Automotive

Alternet Systems (PK)

TPT Global Tech (CE)

International Star (PK)

Enzolytics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions